PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $505,447 | -23.1% | 48,931 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $657,545 | +129849.6% | 50,156 | +10.7% | 0.00% | 0.0% |
| Q1 2023 | $506 | +37.5% | 45,290 | +3.6% | 0.00% | – |
| Q4 2022 | $368 | -99.9% | 43,707 | +3.2% | 0.00% | -100.0% |
| Q3 2022 | $705,000 | +22.0% | 42,343 | +7.9% | 0.00% | 0.0% |
| Q2 2022 | $578,000 | -12.7% | 39,250 | +47.0% | 0.00% | 0.0% |
| Q1 2022 | $662,000 | -17.7% | 26,701 | +6.4% | 0.00% | 0.0% |
| Q4 2021 | $804,000 | -12.7% | 25,084 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $921,000 | -14.2% | 25,590 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $1,074,000 | +87.1% | 24,343 | +93.9% | 0.00% | 0.0% |
| Q1 2021 | $574,000 | -28.5% | 12,555 | +7.9% | 0.00% | 0.0% |
| Q4 2020 | $803,000 | – | 11,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |